Gut bacterial composition in a mouse model of Parkinsonâs disease
In: Beneficial MicrobesSearch for other papers by P. Perez-Pardo in
Current site
Google Scholar
Search for other papers by H.B. Dodiya in
Current site
Google Scholar
Search for other papers by P.A. Engen in
Current site
Google Scholar
Search for other papers by A. Naqib in
Current site
Google Scholar
Search for other papers by C.B. Forsyth in
Current site
Google Scholar
Search for other papers by S.J. Green in
Current site
Google Scholar
Nutricia Research, Uppsalalaan 12, 3584 CT Utrecht, the Netherlands.
Search for other papers by J. Garssen in
Current site
Google Scholar
Search for other papers by A. Keshavarzian in
Current site
Google Scholar
Institute for Risk Assessment Sciences, Faculty of Veterinary Medicine, Utrecht University, Yalelaan 104, 3584 CM Utrecht, the Netherlands.
Search for other papers by A.D. Kraneveld in
Current site
Google Scholar
The mechanism of neurodegeneration in Parkinsonâs disease (PD) remains unknown but it has been hypothesised that the intestinal tract could be an initiating and contributing factor to the neurodegenerative processes. In PD patients as well as in animal models for PD, alpha-synuclein-positive enteric neurons in the colon and evidence of colonic inflammation have been demonstrated. Moreover, several studies reported pro-inflammatory bacterial dysbiosis in PD patients. Here, we report for the first time significant changes in the composition of caecum mucosal associated and luminal microbiota and the associated metabolic pathways in a rotenone-induced mouse model for PD. The mouse model for PD, induced by the pesticide rotenone, is associated with an imbalance in the gut microbiota, characterised by a significant decrease in the relative abundance of the beneficial commensal bacteria genus Bifidobacterium. Overall, intestinal bacterial dysbiosis might play an important role in both the disruption of intestinal epithelial integrity and intestinal inflammation, which could lead or contribute to the observed alpha-synuclein aggregation and PD pathology in the intestine and central nervous system in the oral rotenone mouse model of PD.
-
Abbott, R.D., Petrovitch, H., White, L.R., Masaki, K.H., Tanner, C.M., Curb, J.D., Grandinetti, A., Blanchette, P.L., Popper, J.S. and Ross, G.W., 2001. Frequency of bowel movements and the future risk of Parkinsonâs disease. Neurology 57: 456-462.
'Frequency of bowel movements and the future risk of Parkinsonâs disease ' () 57 Neurology : 456 -462.
-
Adams-Carr, K.L., Bestwick, J.P., Shribman, S., Lees, A., Schrag, A. and Noyce, A.J., 2016. Constipation preceding Parkinsonâs disease: a systematic review and meta-analysis. Journal of Neurology, Neurosurgery, and Psychiatry 87: 710-716.
'Constipation preceding Parkinsonâs disease: a systematic review and meta-analysis ' () 87 Journal of Neurology, Neurosurgery, and Psychiatry : 710 -716.
-
Basson, A., Trotter, A., Rodriguez-Palacios, A. and Cominelli, F., 2016. Mucosal interactions between genetics, diet, and microbiome in inflammatory bowel disease. Frontiers in Immunology 7: 290.
'Mucosal interactions between genetics, diet, and microbiome in inflammatory bowel disease ' () 7 Frontiers in Immunology : 290.
-
Bedarf, J.R., Hildebrand, F., Coelho, L.P., Sunagawa, S., Bahram, M., Goeser, F., Bork, P. and Wüllner, U., 2017. Functional implications of microbial and viral gut metagenome changes in early stage L-DOPA-naïve Parkinsonâs disease patients. Genome Medicine 9: 39.
'Functional implications of microbial and viral gut metagenome changes in early stage L-DOPA-naïve Parkinsonâs disease patients ' () 9 Genome Medicine : 39.
-
Boudry, G., Hamilton, M.K., Chichlowski, M., Wickramasinghe, S., Barile, D., Kalanetra, K.M., Mills, D.A. and Raybould, H.E., 2017. Bovine milk oligosaccharides decrease gut permeability and improve inflammation and microbial dysbiosis in diet-induced obese mice. Journal of Dairy Science 100: 2471-2481.
'Bovine milk oligosaccharides decrease gut permeability and improve inflammation and microbial dysbiosis in diet-induced obese mice ' () 100 Journal of Dairy Science : 2471 -2481.
-
Braak, H. and Del Tredici, K., 2008. Nervous system pathology in sporadic Parkinson disease. Neurology 70: 1916-1925.
'Nervous system pathology in sporadic Parkinson disease ' () 70 Neurology : 1916 -1925.
-
Brown, K., Abbott, D.W., Uwiera, R.R.E. and Inglis, G.D., 2017. Removal of the cecum affects intestinal fermentation, enteric bacterial community structure, and acute colitis in mice. Gut Microbes 11: 1-18.
'Removal of the cecum affects intestinal fermentation, enteric bacterial community structure, and acute colitis in mice ' () 11 Gut Microbes : 1 -18.
-
Campbell, B.C., Li, Q.X., Culvenor, J.G., Jäkälä, P., Cappai, R., Beyreuther, K., Masters, C.L. and McLean, C.A., 2000. Accumulation of insoluble alpha-synuclein in dementia with Lewy bodies. Neurobiology of Disease 7: 192-200.
'Accumulation of insoluble alpha-synuclein in dementia with Lewy bodies ' () 7 Neurobiology of Disease : 192 -200.
-
Canani, R.B., Costanzo, M.D., Leone, L., Pedata, M., Meli, R. and Calignano, A., 2011. Potential beneficial effects of butyrate in intestinal and extraintestinal diseases. World Journal of Gastroenterology 17: 1519-1528.
'Potential beneficial effects of butyrate in intestinal and extraintestinal diseases ' () 17 World Journal of Gastroenterology : 1519 -1528.
-
Caporaso, J.G., Kuczynski, J., Stombaugh, J., Bittinger, K., Bushman, F.D., Costello, E.K., Fierer, N., Peña, A.G., Goodrich, J.K., Gordon, J.I., Huttley, G.A., Kelley, S.T., Knights, D., Koenig, J.E., Ley, R.E., Lozupone, C.A., McDonald, D., Muegge, B.D., Pirrung, M., Reeder, J., Sevinsky, J.R., Turnbaugh, P.J., Walters, W.A., Widmann, J., Yatsunenko, T., Zaneveld, J. and Knight, R., 2010. QIIME allows analysis of high-throughput community sequencing data. Nature Methods 7: 335-336.
'QIIME allows analysis of high-throughput community sequencing data ' () 7 Nature Methods : 335 -336.
-
Caporaso, J.G., Lauber, C.L., Walters, W.A., Berg-Lyons, D., Huntley, J., Fierer, N., Owens, S.M., Betley, J., Fraser, L., Bauer, M., Gormley, N., Gilbert, J.A., Smith, G., Knight, R., 2012. Ultra-high-throughput microbial community analysis on the Illumina HiSeq and MiSeq platforms. ISME Journal 6: 1621-1624.
'Ultra-high-throughput microbial community analysis on the Illumina HiSeq and MiSeq platforms ' () 6 ISME Journal : 1621 -1624.
-
Caricilli, A.M., Castoldi, A. and Câmara, N.O.S., 2014. Intestinal barrier: a gentlemenâs agreement between microbiota and immunity. World Journal of Gastrointestinal Pathophysiology 5: 18-32.
'Intestinal barrier: a gentlemenâs agreement between microbiota and immunity ' () 5 World Journal of Gastrointestinal Pathophysiology : 18 -32.
-
Carroll, I.M., Ringel-Kulka, T., Keku, T.O., Chang, Y.-H., Packey, C.D., Sartor, R.B. and Ringel, Y., 2011. Molecular analysis of the luminal- and mucosal-associated intestinal microbiota in diarrhea-predominant irritable bowel syndrome. American Journal of Physiology â Gastrointestinal and Liver Physiology 301: G799-807.
'Molecular analysis of the luminal- and mucosal-associated intestinal microbiota in diarrhea-predominant irritable bowel syndrome ' () 301 American Journal of Physiology â Gastrointestinal and Liver Physiology : G799 -807.
-
Chaudhuri, K.R. and Schapira, A.H.V., 2009. Non-motor symptoms of Parkinsonâs disease: dopaminergic pathophysiology and treatment. The Lancet Neurology 8: 464-474.
'Non-motor symptoms of Parkinsonâs disease: dopaminergic pathophysiology and treatment ' () 8 The Lancet Neurology : 464 -474.
-
Clapp, M., Aurora, N., Herrera, L., Bhatia, M., Wilen, E. and Wakefield, S., 2017. Gut microbiotaâs effect on mental health: the gut-brain axis. Clinical Practice 7: 987.
'Gut microbiotaâs effect on mental health: the gut-brain axis ' () 7 Clinical Practice : 987.
-
Clarke, K.R., 1993. Non-parametric multivariate analyses of changes in community structure. Australian Journal of Ecology 18: 117-143.
'Non-parametric multivariate analyses of changes in community structure ' () 18 Australian Journal of Ecology : 117 -143.
-
Crossman, A.R., 1989. Neural mechanisms in disorders of movement. Comparative Biochemistry and Physiology A 93: 141-149.
'Neural mechanisms in disorders of movement ' () 93 Comparative Biochemistry and Physiology A : 141 -149.
-
Cryan, J.F. and Dinan, T.G., 2012. Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour. Nature Reviews Neuroscience 13: 701-712.
'Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour ' () 13 Nature Reviews Neuroscience : 701 -712.
-
De Rijk, M.C., Launer, L.J., Berger, K., Breteler, M.M., Dartigues, J.F., Baldereschi, M., Fratiglioni, L., Lobo, A., Martinez-Lage, J., Trenkwalder, C. and Hofman, A., 2000. Prevalence of Parkinsonâs disease in Europe: a collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group. Neurology 54: S21-23.
'Prevalence of Parkinsonâs disease in Europe: a collaborative study of population-based cohorts ' () 54 Neurology : S21 -23.
-
Deleidi, M. and Gasser, T., 2013. The role of inflammation in sporadic and familial Parkinsonâs disease. Cellular and Molecular Life Sciences 70: 4259-4273.
'The role of inflammation in sporadic and familial Parkinsonâs disease ' () 70 Cellular and Molecular Life Sciences : 4259 -4273.
-
Desplats, P., Lee, H.-J., Bae, E.-J., Patrick, C., Rockenstein, E., Crews, L., Spencer, B., Masliah, E. and Lee, S.-J., 2009. Inclusion formation and neuronal cell death through neuron-to-neuron transmission of alpha-synuclein. Proceedings of the National Academy of Sciences of the USA 106: 13010-13015.
'Inclusion formation and neuronal cell death through neuron-to-neuron transmission of alpha-synuclein ' () 106 Proceedings of the National Academy of Sciences of the USA : 13010 -13015.
-
Dias, V., Junn, E. and Mouradian, M.M., 2013. The role of oxidative stress in Parkinsonâs disease. Journal of Parkinsonâs Disease 3: 461-491.
'The role of oxidative stress in Parkinsonâs disease ' () 3 Journal of Parkinsonâs Disease : 461 -491.
-
Durbán, A., Abellán, J.J., Jiménez-Hernández, N., Ponce, M., Ponce, J., Sala, T., DâAuria, G., Latorre, A. and Moya, A., 2011. Assessing gut microbial diversity from feces and rectal mucosa. Microbial Ecology 61: 123-133.
'Assessing gut microbial diversity from feces and rectal mucosa ' () 61 Microbial Ecology : 123 -133.
-
Edgar, R.C., 2010. Search and clustering orders of magnitude faster than BLAST. Bioinformatics 26: 2460-2461.
'Search and clustering orders of magnitude faster than BLAST ' () 26 Bioinformatics : 2460 -2461.
-
Engen, P.A., Dodiya, H.B., Naqib, A., Forsyth, C.B., Green, S.J., Voigt, R.M., Kordower, J.H., Mutlu, E.A., Shannon, K.M. and Keshavarzian, A., 2017. The potential role of gut-derived inflammation in multiple system atrophy. Journal of Parkinsonâs Disease 7: 331-346.
'The potential role of gut-derived inflammation in multiple system atrophy ' () 7 Journal of Parkinsonâs Disease : 331 -346.
-
Erny, D., HrabÄ de Angelis, A.L., Jaitin, D., Wieghofer, P., Staszewski, O., David, E., Keren-Shaul, H., Mahlakoiv, T., Jakobshagen, K., Buch, T., Schwierzeck, V., Utermöhlen, O., Chun, E., Garrett, W.S., McCoy, K.D., Diefenbach, A., Staeheli, P., Stecher, B., Amit, I. and Prinz, M., 2015. Host microbiota constantly control maturation and function of microglia in the CNS. Nature Neuroscience 18: 965-977.
'Host microbiota constantly control maturation and function of microglia in the CNS ' () 18 Nature Neuroscience : 965 -977.
-
Fasano, A., Visanji, N.P., Liu, L.W.C., Lang, A.E. and Pfeiffer, R.F., 2015. Gastrointestinal dysfunction in Parkinsonâs disease. The Lancet Neurology 14: 625-639.
'Gastrointestinal dysfunction in Parkinsonâs disease ' () 14 The Lancet Neurology : 625 -639.
-
Forsyth, C.B., Shannon, K.M., Kordower, J.H., Voigt, R.M., Shaikh, M., Jaglin, J.A., Estes, J.D., Dodiya, H.B. and Keshavarzian, A., 2011. Increased intestinal permeability correlates with sigmoid mucosa alpha-synuclein staining and endotoxin exposure markers in early Parkinsonâs disease. PLoS ONE 6: e28032.
'Increased intestinal permeability correlates with sigmoid mucosa alpha-synuclein staining and endotoxin exposure markers in early Parkinsonâs disease ' () 6 PLoS ONE : e28032.
-
Fröhlich, E.E., Farzi, A., Mayerhofer, R., Reichmann, F., JaÄan, A., Wagner, B., Zinser, E., Bordag, N., Magnes, C., Fröhlich, E., Kashofer, K., Gorkiewicz, G., Holzer, P., 2016. Cognitive impairment by antibiotic-induced gut dysbiosis: analysis of gut microbiota-brain communication. Brain, Behavior, and Immunity 56: 140-155.
'Cognitive impairment by antibiotic-induced gut dysbiosis: analysis of gut microbiota-brain communication ' () 56 Brain, Behavior, and Immunity : 140 -155.
-
Gabrielli, M., Bonazzi, P., Scarpellini, E., Bendia, E., Lauritano, E.C., Fasano, A., Ceravolo, M.G., Capecci, M., Rita Bentivoglio, A., Provinciali, L., Tonali, P.A. and Gasbarrini, A., 2011. Prevalence of small intestinal bacterial overgrowth in Parkinsonâs disease. Movement Disorders Journal 26: 889-892.
'Prevalence of small intestinal bacterial overgrowth in Parkinsonâs disease ' () 26 Movement Disorders Journal : 889 -892.
-
Gihring, T.M., Green, S.J. and Schadt, C.W., 2012. Massively parallel rRNA gene sequencing exacerbates the potential for biased community diversity comparisons due to variable library sizes. Environmental Microbiology 14: 285-290.
'Massively parallel rRNA gene sequencing exacerbates the potential for biased community diversity comparisons due to variable library sizes ' () 14 Environmental Microbiology : 285 -290.
-
Glass, C.K., Saijo, K., Winner, B., Marchetto, M.C. and Gage, F.H., 2010. Mechanisms underlying inflammation in neurodegeneration. Cell 140: 918-934.
'Mechanisms underlying inflammation in neurodegeneration ' () 140 Cell : 918 -934.
-
Gray, M.T., Munoz, D.G., Gray, D.A., Schlossmacher, M.G. and Woulfe, J.M., 2014. Alpha-synuclein in the appendiceal mucosa of neurologically intact subjects. Movement Disorders Journal 29: 991-998.
'Alpha-synuclein in the appendiceal mucosa of neurologically intact subjects ' () 29 Movement Disorders Journal : 991 -998.
-
Greene, J.G., Noorian, A.R. and Srinivasan, S., 2009. Delayed gastric emptying and enteric nervous system dysfunction in the rotenone model of Parkinsonâs disease. Experimental Neurology 218: 154-161.
'Delayed gastric emptying and enteric nervous system dysfunction in the rotenone model of Parkinsonâs disease ' () 218 Experimental Neurology : 154 -161.
-
Guan, J., Pavlovic, D., Dalkie, N., Waldvogel, H.J., OâCarroll, S.J., Green, C.R. and Nicholson, L.F.B., 2013. Vascular degeneration in Parkinsonâs disease. Brain Pathology 23: 154-164.
'Vascular degeneration in Parkinsonâs disease ' () 23 Brain Pathology : 154 -164.
-
Hakansson, A. and Molin, G., 2011. Gut microbiota and inflammation. Nutrients 3: 637-682.
'Gut microbiota and inflammation ' () 3 Nutrients : 637 -682.
-
Hasegawa, S., Goto, S., Tsuji, H., Okuno, T., Asahara, T., Nomoto, K., Shibata, A., Fujisawa, Y., Minato, T., Okamoto, A., Ohno, K. and Hirayama, M., 2015. Intestinal dysbiosis and lowered serum Lipopolysaccharide-binding protein in Parkinsonâs disease. PLoS ONE 10: e0142164.
'Intestinal dysbiosis and lowered serum Lipopolysaccharide-binding protein in Parkinsonâs disease ' () 10 PLoS ONE : e0142164.
-
Hawkes, C.H., Del Tredici, K. and Braak, H., 2010. A timeline for Parkinsonâs disease. Parkinsonism and Related Disorders 16: 79-84.
'A timeline for Parkinsonâs disease ' () 16 Parkinsonism and Related Disorders : 79 -84.
-
Hawkes, C.H., Del Tredici, K. and Braak, H., 2009. Parkinsonâs disease: the dual hit theory revisited. Annals of the N.Y. Academy of Sciences 1170: 615-622.
'Parkinsonâs disease: the dual hit theory revisited ' () 1170 Academy of Sciences : 615 -622.
-
Hildebrand, F., Nguyen, T.L.A., Brinkman, B., Yunta, R.G., Cauwe, B., Vandenabeele, P., Liston, A. and Raes, J., 2013. Inflammation-associated enterotypes, host genotype, cage and inter-individual effects drive gut microbiota variation in common laboratory mice. Genome Biology 14: R4.
'Inflammation-associated enterotypes, host genotype, cage and inter-individual effects drive gut microbiota variation in common laboratory mice ' () 14 Genome Biology : R4.
-
Hill-Burns, E.M., Debelius, J.W., Morton, J.T., Wissemann, W.T., Lewis, M.R., Wallen, Z.D., Peddada, S.D., Factor, S.A., Molho, E., Zabetian, C.P., Knight, R. and Payami, H., 2017. Parkinsonâs disease and Parkinsonâs disease medications have distinct signatures of the gut microbiome. Movement Disorders Journal 32: 739-749.
'Parkinsonâs disease and Parkinsonâs disease medications have distinct signatures of the gut microbiome ' () 32 Movement Disorders Journal : 739 -749.
-
Hilton, D., Stephens, M., Kirk, L., Edwards, P., Potter, R., Zajicek, J., Broughton, E., Hagan, H. and Carroll, C., 2014. Accumulation of α-synuclein in the bowel of patients in the pre-clinical phase of Parkinsonâs disease. Acta Neuropathology 127: 235-241.
'Accumulation of α-synuclein in the bowel of patients in the pre-clinical phase of Parkinsonâs disease ' () 127 Acta Neuropathology : 235 -241.
-
Holmqvist, S., Chutna, O., Bousset, L., Aldrin-Kirk, P., Li, W., Björklund, T., Wang, Z.-Y., Roybon, L., Melki, R., Li, J.-Y., 2014. Direct evidence of Parkinson pathology spread from the gastrointestinal tract to the brain in rats. Acta Neuropathology 128: 805-820.
'Direct evidence of Parkinson pathology spread from the gastrointestinal tract to the brain in rats ' () 128 Acta Neuropathology : 805 -820.
-
Hopfner, F., Künstner, A., Müller, S.H., Künzel, S., Zeuner, K.E., Margraf, N.G., Deuschl, G., Baines, J.F. and Kuhlenbäumer, G., 2017. Gut microbiota in Parkinson disease in a northern German cohort. Brain Research 1667: 41-45.
'Gut microbiota in Parkinson disease in a northern German cohort ' () 1667 Brain Research : 41 -45.
-
Huang, X.-Z., Zhu, L.-B., Li, Z.-R. and Lin, J., 2013. Bacterial colonization and intestinal mucosal barrier development. World Journal of Clinical Pediatrics 2: 46-53.
'Bacterial colonization and intestinal mucosal barrier development ' () 2 World Journal of Clinical Pediatrics : 46 -53.
-
Hufeldt, M.R., Nielsen, D.S., Vogensen, F.K., Midtvedt, T. and Hansen, A.K., 2010. Variation in the gut microbiota of laboratory mice is related to both genetic and environmental factors. Comparative Medicine 60: 336-347.
'Variation in the gut microbiota of laboratory mice is related to both genetic and environmental factors ' () 60 Comparative Medicine : 336 -347.
-
Ivanov, I.I. and Honda, K., 2012. Intestinal commensal microbes as immune modulators. Cell Host Microbe 12: 496-508.
'Intestinal commensal microbes as immune modulators ' () 12 Cell Host Microbe : 496 -508.
-
Johnson, M.E., Stringer, A. and Bobrovskaya, L., 2018. Rotenone induces gastrointestinal pathology and microbiota alterations in a rat model of Parkinsonâs disease. Neurotoxicology 65: 174-185.
'Rotenone induces gastrointestinal pathology and microbiota alterations in a rat model of Parkinsonâs disease ' () 65 Neurotoxicology : 174 -185.
-
Kanehisa, M. and Goto, S., 2000. KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Research 28: 27-30.
'KEGG: kyoto encyclopedia of genes and genomes ' () 28 Nucleic Acids Research : 27 -30.
-
Kanehisa, M., Goto, S., Sato, Y., Furumichi, M. and Tanabe, M., 2012. KEGG for integration and interpretation of large-scale molecular data sets. Nucleic Acids Research 40: D109-114.
'KEGG for integration and interpretation of large-scale molecular data sets ' () 40 Nucleic Acids Research : D109 -114.
-
Kelly, L.P., Carvey, P.M., Keshavarzian, A., Shannon, K.M., Shaikh, M., Bakay, R.A.E. and Kordower, J.H., 2014. Progression of intestinal permeability changes and alpha-synuclein expression in a mouse model of Parkinsonâs disease. Movement Disorders Journal 29: 999-1009.
'Progression of intestinal permeability changes and alpha-synuclein expression in a mouse model of Parkinsonâs disease ' () 29 Movement Disorders Journal : 999 -1009.
-
Keshavarzian, A., Green, S.J., Engen, P.A., Voigt, R.M., Naqib, A., Forsyth, C.B., Mutlu, E. and Shannon, K.M., 2015. Colonic bacterial composition in Parkinsonâs disease. Movement Disorders Journal 30: 1351-1360.
'Colonic bacterial composition in Parkinsonâs disease ' () 30 Movement Disorders Journal : 1351 -1360.
-
Kim, K.-A., Gu, W., Lee, I.-A., Joh, E.-H. and Kim, D.-H., 2012. High fat diet-induced gut microbiota exacerbates inflammation and obesity in mice via the TLR4 signaling pathway. PLoS ONE 7: e47713.
'High fat diet-induced gut microbiota exacerbates inflammation and obesity in mice via the TLR4 signaling pathway ' () 7 PLoS ONE : e47713.
-
Kostic, A.D., Howitt, M.R. and Garrett, W.S., 2013. Exploring host-microbiota interactions in animal models and humans. Genes & Development 27: 701-718.
'Exploring host-microbiota interactions in animal models and humans ' () 27 Genes & Development : 701 -718.
-
Langille, M.G.I., Zaneveld, J., Caporaso, J.G., McDonald, D., Knights, D., Reyes, J.A., Clemente, J.C., Burkepile, D.E., Vega Thurber, R.L., Knight, R., Beiko, R.G. and Huttenhower, C., 2013. Predictive functional profiling of microbial communities using 16S rRNA marker gene sequences. Nature Biotechnology 31: 814-821.
'Predictive functional profiling of microbial communities using 16S rRNA marker gene sequences ' () 31 Nature Biotechnology : 814 -821.
-
Lathrop, S.K., Bloom, S.M., Rao, S.M., Nutsch, K., Lio, C.-W., Santacruz, N., Peterson, D.A., Stappenbeck, T.S. and Hsieh, C.-S., 2011. Peripheral education of the immune system by colonic commensal microbiota. Nature 478: 250-254.
'Peripheral education of the immune system by colonic commensal microbiota ' () 478 Nature : 250 -254.
-
Laukens, D., Brinkman, B.M., Raes, J., De Vos, M. and Vandenabeele, P., 2016. Heterogeneity of the gut microbiome in mice: guidelines for optimizing experimental design. FEMS Microbiology Reviews 40: 117-132.
'Heterogeneity of the gut microbiome in mice: guidelines for optimizing experimental design ' () 40 FEMS Microbiology Reviews : 117 -132.
-
Leclercq, S., Forsythe, P. and Bienenstock, J., 2016. Posttraumatic Stress Disorder: does the gut microbiome hold the key? Canadian Journal of Psychiatry 61: 204-213.
'Posttraumatic Stress Disorder: does the gut microbiome hold the key? ' () 61 Canadian Journal of Psychiatry : 204 -213.
-
Lee, S.-M., Han, H.W. and Yim, S.Y., 2015. Beneficial effects of soy milk and fiber on high cholesterol diet-induced alteration of gut microbiota and inflammatory gene expression in rats. Food & Function 6: 492-500.
'Beneficial effects of soy milk and fiber on high cholesterol diet-induced alteration of gut microbiota and inflammatory gene expression in rats ' () 6 Food & Function : 492 -500.
-
Li, Q., Han, Y., Dy, A.B.C. and Hagerman, R.J., 2017. The gut microbiota and autism spectrum disorders. Frontiers in Cellular Neuroscience 11: 120.
'The gut microbiota and autism spectrum disorders ' () 11 Frontiers in Cellular Neuroscience : 120.
-
Li, W., Wu, X., Hu, X., Wang, T., Liang, S., Duan, Y., Jin, F. and Qin, B., 2017. Structural changes of gut microbiota in Parkinsonâs disease and its correlation with clinical features. Science China Life Sciences 60: 1223-1233.
'Structural changes of gut microbiota in Parkinsonâs disease and its correlation with clinical features ' () 60 Science China Life Sciences : 1223 -1233.
-
Louis, P. and Flint, H.J., 2009. Diversity, metabolism and microbial ecology of butyrate-producing bacteria from the human large intestine. FEMS Microbiology Letters 294: 1-8.
'Diversity, metabolism and microbial ecology of butyrate-producing bacteria from the human large intestine ' () 294 FEMS Microbiology Letters : 1 -8.
-
Luna, E. and Luk, K.C., 2015. Bent out of shape: α-Synuclein misfolding and the convergence of pathogenic pathways in Parkinsonâs disease. FEBS Letters 589: 3749-3759.
'Bent out of shape: α-Synuclein misfolding and the convergence of pathogenic pathways in Parkinsonâs disease ' () 589 FEBS Letters : 3749 -3759.
-
Macfarlane, S. and Macfarlane, G.T., 2003. Regulation of short-chain fatty acid production. Proceedings of the Nutrition Society 62: 67-72.
'Regulation of short-chain fatty acid production ' () 62 Proceedings of the Nutrition Society : 67 -72.
-
Martinez-Martin, P., 2011. The importance of non-motor disturbances to quality of life in Parkinsonâs disease. Journal of the Neurological Sciences 310: 12-16.
'The importance of non-motor disturbances to quality of life in Parkinsonâs disease ' () 310 Journal of the Neurological Sciences : 12 -16.
-
McDermott, A.J. and Huffnagle, G.B., 2014. The microbiome and regulation of mucosal immunity. Immunology 142: 24-31.
'The microbiome and regulation of mucosal immunity ' () 142 Immunology : 24 -31.
-
McDonald, D., Clemente, J.C., Kuczynski, J., Rideout, J.R., Stombaugh, J., Wendel, D., Wilke, A., Huse, S., Hufnagle, J., Meyer, F., Knight, R. and Caporaso, J.G., 2012. The Biological Observation Matrix (BIOM) format or: how I learned to stop worrying and love the ome-ome. GigaScience 1: 7.
'The Biological Observation Matrix (BIOM) format or: how I learned to stop worrying and love the ome-ome ' () 1 GigaScience : 7.
-
Minato, T., Maeda, T., Fujisawa, Y., Tsuji, H., Nomoto, K., Ohno, K. and Hirayama, M., 2017. Progression of Parkinsonâs disease is associated with gut dysbiosis: two-year follow-up study. PLoS ONE 12: e0187307.
'Progression of Parkinsonâs disease is associated with gut dysbiosis: two-year follow-up study ' () 12 PLoS ONE : e0187307.
-
Miyake, S., Kim, S., Suda, W., Oshima, K., Nakamura, M., Matsuoka, T., Chihara, N., Tomita, A., Sato, W., Kim, S.-W., Morita, H., Hattori, M. and Yamamura, T., 2015. Dysbiosis in the gut microbiota of patients with multiple sclerosis, with a striking depletion of species belonging to clostridia XIVa and IV clusters. PLoS ONE 10: e0137429.
'Dysbiosis in the gut microbiota of patients with multiple sclerosis, with a striking depletion of species belonging to clostridia XIVa and IV clusters ' () 10 PLoS ONE : e0137429.
-
Müller, B., Assmus, J., Herlofson, K., Larsen, J.P. and Tysnes, O.-B., 2013. Importance of motor vs. non-motor symptoms for health-related quality of life in early Parkinsonâs disease. Parkinsonism and Related Disorders 19: 1027-1032.
'Importance of motor vs. non-motor symptoms for health-related quality of life in early Parkinsonâs disease ' () 19 Parkinsonism and Related Disorders : 1027 -1032.
-
Nguyen, T.L.A., Vieira-Silva, S., Liston, A. and Raes, J., 2015. How informative is the mouse for human gut microbiota research? Disease Models & Mechanisms 8: 1-16.
'How informative is the mouse for human gut microbiota research? ' () 8 Disease Models & Mechanisms : 1 -16.
-
Nishio, J. and Honda, K., 2012. Immunoregulation by the gut microbiota. Cellular and Molecular Life Sciences 69: 3635-3650.
'Immunoregulation by the gut microbiota ' () 69 Cellular and Molecular Life Sciences : 3635 -3650.
-
Nussbaum, R.L. and Ellis, C.E., 2003. Alzheimerâs disease and Parkinsonâs disease. New England Journal of Medicine 348: 1356-1364.
'Alzheimerâs disease and Parkinsonâs disease ' () 348 New England Journal of Medicine : 1356 -1364.
-
Pan-Montojo, F., Anichtchik, O., Dening, Y., Knels, L., Pursche, S., Jung, R., Jackson, S., Gille, G., Spillantini, M.G., Reichmann, H., Funk, R.H.W., 2010. Progression of Parkinsonâs disease pathology is reproduced by intragastric administration of rotenone in mice. PLoS ONE 5: e8762.
'Progression of Parkinsonâs disease pathology is reproduced by intragastric administration of rotenone in mice ' () 5 PLoS ONE : e8762.
-
Perez-Pardo, P., Dodiya, H.B., Broersen, L.M., Douna, H., Van Wijk, N., Lopes da Silva, S., Garssen, J., Keshavarzian, A. and Kraneveld, A.D., 2017. Gut-brain and brain-gut axis in Parkinsonâs disease models: effects of a uridine and fish oil diet. Nutritional Neuroscience 9: 1-12.
'Gut-brain and brain-gut axis in Parkinsonâs disease models: effects of a uridine and fish oil diet ' () 9 Nutritional Neuroscience : 1 -12.
-
Petrov, V.A., Saltykova, I.V., Zhukova, I.A., Alifirova, V.M., Zhukova, N.G., Dorofeeva, Y.B., Tyakht, A.V., Kovarsky, B.A., Alekseev, D.G., Kostryukova, E.S., Mironova, Y.S., Izhboldina, O.P., Nikitina, M.A., Perevozchikova, T.V., Fait, E.A., Babenko, V.V., Vakhitova, M.T., Govorun, V.M. and Sazonov, A.E., 2017. Analysis of gut microbiota in patients with Parkinsonâs disease. Bulletin of Experimental Biology and Medicine 162: 734-737.
'Analysis of gut microbiota in patients with Parkinsonâs disease ' () 162 Bulletin of Experimental Biology and Medicine : 734 -737.
-
Pfeiffer, R.F., 2011. Gastrointestinal dysfunction in Parkinsonâs disease. Parkinsonism and Related Disorders 17: 10-15.
'Gastrointestinal dysfunction in Parkinsonâs disease ' () 17 Parkinsonism and Related Disorders : 10 -15.
-
Prusiner, S.B., Woerman, A.L., Mordes, D.A., Watts, J.C., Rampersaud, R., Berry, D.B., Patel, S., Oehler, A., Lowe, J.K., Kravitz, S.N., Geschwind, D.H., Glidden, D.V., Halliday, G.M., Middleton, L.T., Gentleman, S.M., Grinberg, L.T. and Giles, K., 2015. Evidence for α-synuclein prions causing multiple system atrophy in humans with parkinsonism. Proceedings of the National Academy of Sciences of the USA 112: E5308-5317.
'Evidence for α-synuclein prions causing multiple system atrophy in humans with parkinsonism ' () 112 Proceedings of the National Academy of Sciences of the USA : E5308 -5317.
-
Ransohoff, R.M., 2016. How neuroinflammation contributes to neurodegeneration. Science 353: 777-783.
'How neuroinflammation contributes to neurodegeneration ' () 353 Science : 777 -783.
-
Rogers, G.B., Keating, D.J., Young, R.L., Wong, M.-L., Licinio, J. and Wesselingh, S., 2016. From gut dysbiosis to altered brain function and mental illness: mechanisms and pathways. Molecular Psychiatry 21: 738-748.
'From gut dysbiosis to altered brain function and mental illness: mechanisms and pathways ' () 21 Molecular Psychiatry : 738 -748.
-
Sampson, T.R., Debelius, J.W., Thron, T., Janssen, S., Shastri, G.G., Ilhan, Z.E., Challis, C., Schretter, C.E., Rocha, S., Gradinaru, V., Chesselet, M.-F., Keshavarzian, A., Shannon, K.M., Krajmalnik-Brown, R., Wittung-Stafshede, P., Knight, R. and Mazmanian, S.K., 2016. Gut microbiota regulate motor deficits and neuroinflammation in a model of Parkinsonâs disease. Cell 167: 1469-1480.
'Gut microbiota regulate motor deficits and neuroinflammation in a model of Parkinsonâs disease ' () 167 Cell : 1469 -1480.
-
Scheperjans, F., Aho, V., Pereira, P.A.B., Koskinen, K., Paulin, L., Pekkonen, E., Haapaniemi, E., Kaakkola, S., Eerola-Rautio, J., Pohja, M., Kinnunen, E., Murros, K. and Auvinen, P., 2015. Gut microbiota are related to Parkinsonâs disease and clinical phenotype. Movement Disorders Journal 30: 350-358.
'Gut microbiota are related to Parkinsonâs disease and clinical phenotype ' () 30 Movement Disorders Journal : 350 -358.
-
Shannon, K.M., Keshavarzian, A., Dodiya, H.B., Jakate, S. and Kordower, J.H., 2012. Is alpha-synuclein in the colon a biomarker for premotor Parkinsonâs disease? Evidence from 3 cases. Movement Disorders Journal 27: 716-719.
'Is alpha-synuclein in the colon a biomarker for premotor Parkinsonâs disease? ' () 27 Movement Disorders Journal : 716 -719.
-
Shults, C.W., 2006. Lewy bodies. Proceedings of the National Academy of Sciences of the USA 103: 1661-1668.
'Lewy bodies ' () 103 Proceedings of the National Academy of Sciences of the USA : 1661 -1668.
-
Stokholm, M.G., Danielsen, E.H., Hamilton-Dutoit, S.J. and Borghammer, P., 2016. Pathological α-synuclein in gastrointestinal tissues from prodromal Parkinson disease patients. Annals of Neurology 79: 940-949.
'Pathological α-synuclein in gastrointestinal tissues from prodromal Parkinson disease patients ' () 79 Annals of Neurology : 940 -949.
-
Tan, A.H., Mahadeva, S., Thalha, A.M., Gibson, P.R., Kiew, C.K., Yeat, C.M., Ng, S.W., Ang, S.P., Chow, S.K., Tan, C.T., Yong, H.S., Marras, C., Fox, S.H., Lim, S.-Y., 2014. Small intestinal bacterial overgrowth in Parkinsonâs disease. Parkinsonism and Related Disorders 20: 535-540.
'Small intestinal bacterial overgrowth in Parkinsonâs disease ' () 20 Parkinsonism and Related Disorders : 535 -540.
-
Tasselli, M., Chaumette, T., Paillusson, S., Monnet, Y., Lafoux, A., Huchet-Cadiou, C., Aubert, P., Hunot, S., Derkinderen, P. and Neunlist, M., 2013. Effects of oral administration of rotenone on gastrointestinal functions in mice. Journal of Neurogastroenterology and Motility 25: e183-193.
'Effects of oral administration of rotenone on gastrointestinal functions in mice ' () 25 Journal of Neurogastroenterology and Motility : e183 -193.
-
Unger, M.M., Spiegel, J., Dillmann, K.-U., Grundmann, D., Philippeit, H., Bürmann, J., Faβbender, K., Schwiertz, A. and Schäfer, K.-H., 2016. Short chain fatty acids and gut microbiota differ between patients with Parkinsonâs disease and age-matched controls. Parkinsonism and Related Disorders 32: 66-72.
'Short chain fatty acids and gut microbiota differ between patients with Parkinsonâs disease and age-matched controls ' () 32 Parkinsonism and Related Disorders : 66 -72.
-
Visanji, N.P., Marras, C., Kern, D.S., Al Dakheel, A., Gao, A., Liu, L.W.C., Lang, A.E., Hazrati, L.-N., 2015. Colonic mucosal a-synuclein lacks specificity as a biomarker for Parkinson disease. Neurology 84: 609-616.
'Colonic mucosal a-synuclein lacks specificity as a biomarker for Parkinson disease ' () 84 Neurology : 609 -616.
-
Wexler, H.M., 2007. Bacteroides: the good, the bad, and the nitty-gritty. Clinical Microbiology Reviews 20: 593-621.
'Bacteroides: the good, the bad, and the nitty-gritty ' () 20 Clinical Microbiology Reviews : 593 -621.
-
Yang, X., Qian, Y., Xu, S., Song, Y. and Xiao, Q., 2017. Longitudinal analysis of fecal microbiome and pathologic processes in a rotenone induced mice model of Parkinsonâs disease. Frontiers in Aging Neuroscience 9: 441.
'Longitudinal analysis of fecal microbiome and pathologic processes in a rotenone induced mice model of Parkinsonâs disease ' () 9 Frontiers in Aging Neuroscience : 441.
-
Yoshida, M., 2007. Multiple system atrophy: alpha-synuclein and neuronal degeneration. Neuropathology 27: 484-493.
'Multiple system atrophy: alpha-synuclein and neuronal degeneration ' () 27 Neuropathology : 484 -493.
Supplementary Materials
| All Time | Past 365 days | Past 30 Days | |
|---|---|---|---|
| Abstract Views | 0 | 0 | 0 |
| Full Text Views | 937 | 275 | 42 |
| PDF Views & Downloads | 1055 | 292 | 18 |
Gut bacterial composition in a mouse model of Parkinsonâs disease
In: Beneficial MicrobesSearch for other papers by P. Perez-Pardo in
Current site
Google Scholar
PubMed
Search for other papers by H.B. Dodiya in
Current site
Google Scholar
PubMed
Search for other papers by P.A. Engen in
Current site
Google Scholar
PubMed
Search for other papers by A. Naqib in
Current site
Google Scholar
PubMed
Search for other papers by C.B. Forsyth in
Current site
Google Scholar
PubMed
Search for other papers by S.J. Green in
Current site
Google Scholar
PubMed
Nutricia Research, Uppsalalaan 12, 3584 CT Utrecht, the Netherlands.
Search for other papers by J. Garssen in
Current site
Google Scholar
PubMed
Search for other papers by A. Keshavarzian in
Current site
Google Scholar
PubMed
Institute for Risk Assessment Sciences, Faculty of Veterinary Medicine, Utrecht University, Yalelaan 104, 3584 CM Utrecht, the Netherlands.
Search for other papers by A.D. Kraneveld in
Current site
Google Scholar
PubMed
The mechanism of neurodegeneration in Parkinsonâs disease (PD) remains unknown but it has been hypothesised that the intestinal tract could be an initiating and contributing factor to the neurodegenerative processes. In PD patients as well as in animal models for PD, alpha-synuclein-positive enteric neurons in the colon and evidence of colonic inflammation have been demonstrated. Moreover, several studies reported pro-inflammatory bacterial dysbiosis in PD patients. Here, we report for the first time significant changes in the composition of caecum mucosal associated and luminal microbiota and the associated metabolic pathways in a rotenone-induced mouse model for PD. The mouse model for PD, induced by the pesticide rotenone, is associated with an imbalance in the gut microbiota, characterised by a significant decrease in the relative abundance of the beneficial commensal bacteria genus Bifidobacterium. Overall, intestinal bacterial dysbiosis might play an important role in both the disruption of intestinal epithelial integrity and intestinal inflammation, which could lead or contribute to the observed alpha-synuclein aggregation and PD pathology in the intestine and central nervous system in the oral rotenone mouse model of PD.
| All Time | Past 365 days | Past 30 Days | |
|---|---|---|---|
| Abstract Views | 0 | 0 | 0 |
| Full Text Views | 937 | 275 | 42 |
| PDF Views & Downloads | 1055 | 292 | 18 |
